Extracorporeal membrane oxygenation
- 1 February 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 11 (1) , 87-93
- https://doi.org/10.1097/00075198-200502000-00014
Abstract
Extracorporeal membrane oxygenation (ECMO) has become a more or less accepted standard in the algorithm of advanced acute respiratory distress syndrome therapy in adult patients when all other treatment options have failed. This article reviews the current status of ECMO therapy with particular focus on new technical developments and their potential implications for performance and indications for ECMO therapy. A recently published review on a single-center experience in 255 adult ECMO patients identified using multivariate logistic regression analysis age, sex, initial pH 7.10 or lower and PaO2/FiO2 ratio, and days of mechanical ventilation before ECMO as a significant predictors of survival. Additionally, a careful cost-effectiveness study for neonatal ECMO relating a 4-year base to the UK neonatal ECMO trial has clearly demonstrated cost-effectiveness. Over the years, the technique for ECMO therapy underwent substantial changes in indications and the materials used. Impressive technical progress has been made in pumps, oxygenators, and coating of artificial surfaces, leading to a higher biocompatibility and to a lower rate of procedure-related complications. The potential of new inline pumps in combination with a decreasing rate of procedure-related complications might lead to a re-evaluation of the role of extracorporeal lung support in acute respiratory distress syndrome therapy. A very recent development is the use of spontaneous arteriovenous devices for carbon dioxide removal, allowing significant reduction of ventilator settings at decreased carbon dioxide partial pressures and at increased pH values. Ongoing studies are looking at the potential of this approach to reduce side effects of mechanical ventilation further.Keywords
This publication has 33 references indexed in Scilit:
- Extracorporeal Membrane Oxygenation after Lung Transplantation: Evolving Technique Improves OutcomesThe Annals of Thoracic Surgery, 2004
- Extracorporeal Life Support for Severe Acute Respiratory Distress Syndrome in AdultsAnnals of Surgery, 2004
- Assist–Control Mechanical Ventilation Attenuates Ventilator-induced Diaphragmatic DysfunctionAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO TrialArchives of Disease in Childhood: Fetal & Neonatal, 2004
- Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activationThe Annals of Thoracic Surgery, 2004
- Spontaneous Breathing Improves Lung Aeration in Oleic Acid–induced Lung InjuryAnesthesiology, 2003
- Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopeniaCatheterization and Cardiovascular Interventions, 2002
- Prevalence and Persistence of Heparin/Platelet Factor 4 Antibodies in Patients with Heparin Coated and Noncoated Ventricular Assist DevicesAsaio Journal, 2000
- Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymersCritical Care Medicine, 2000
- TREATMENT OF ACUTE RESPIRATORY FAILURE WITH LOW-FREQUENCY POSITIVE-PRESSURE VENTILATION AND EXTRACORPOREAL REMOVAL OF CO2The Lancet, 1980